While West Virginia's employee health insurance program covers drugs like Ozempic for people with type 2 diabetes, officials ...

Breaking the silence on how generational trauma impacts obesity in Black communities, through one woman's powerful journey ...

The anti-obesity drug Zepbound made by Eli Lilly & Co. could be one of the biggest cost drivers for health insurers and ...

San Diego-based iBio has signed a backloaded agreement with its existing partner AstralBio for a preclinical anti-myostatin ...

Although bipartisan legislation to provide Medicare coverage for obesity treatments has circulated in Congress for more than ...

Since Zepbound was approved by the FDA to treat obesity in late 2023, its maker Eli Lilly has been steadily closing in on ...

I applaud the Biden administration’s recent moves to make these anti-obesity drugs more accessible to people on Medicaid and ...

A MAP has revealed England’s fattest towns with the highest obesity rates. The latest statistics from the NHS have documented ...

On Thursday, iBio, Inc. (NYSE:IBIO) expanded its cardiometabolic and obesity treatment development program by in-licensing a ...

Racial and ethnic disparities are seen in the use of obesity-management medications, according to a study published online ...